Skip to content

A Comparative Study of the Effect of Laser and Acyclovir on Herpes

A Comparison of Diode Laser and aAcyclovir in Treatment of Herpes Labials

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041421752N1
Enrollment
60
Registered
2015-08-23
Start date
2015-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes labialis. vesicular stomatitis virus disease

Interventions

Intervention 1: Treated with 5% acyclovir ointment - 5 times a day. Intervention 2: Treated by laser - Daily radiated for 1 minute. Intervention 3: Laser off.
Treatment - Drugs
Treated with 5% acyclovir ointment - 5 times a day
Treated by laser - Daily radiated for 1 minute
Laser off

Sponsors

Zahedan University of Medicasl Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Development duration for cold sores should be 36 hours or lower; Patients should not have been diagnosed with systematic diseases; Patients should not consume any types of medication during the study. Exclusion criteria: Conversion of cold sore to crust; Patients with systematic disease; Patients who consume medications during the study;Patients who do not complete their treatment;Cold sore that have taken more than 36 hours to form and develop.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Healling Time. Timepoint: Baseline, First day up to Eighth day. Method of measurement: examination.

Secondary

MeasureTime frame
Ulcer Size. Timepoint: Baseline, First day up to Eighth day. Method of measurement: Examination and measurement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mariyeh Honarmand

Zahedan University of Medical Science

honarmand@zaums.ac.ir+98 54 2241 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026